AG001Y2Q

16846-24-5 | Leucomycin V, 3-acetate 4B-(3-methylbutanoate)

Chemical structure of Leucomycin V, 3-acetate 4B-(3-methylbutanoate), CAS 16846-24-5
AG001Y2Q
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 16846-24-5
Catalog Number AG001Y2Q(AGN-PC-0Q99LX)
Chemical Name Leucomycin V, 3-acetate 4B-(3-methylbutanoate)
EC Number 240-871-6
IUPAC Name [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate
InChI InChI=1S/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1
InChI Key XJSFLOJWULLJQS-NGVXBBESSA-N
MDL Number MFCD00210320
Molecular Formula C42H69NO15
Molecular Weight 827.9950
SMILES CC(C)CC(O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](OC(C)=O)CC(O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]3CC=O)=O)[C@H](O)[C@H]2N(C)C)C[C@]1(O)C)=O
UNII HV13HFS217
Synonyms
EN 141, EN-141, EN141, Josamycin, Josamycine, Kitasamycin A3, Leucomycin A3, Turimycin A5, Wilprafen, josamycin, Leucomycin A3, Turimycin A5, Kitasamycin A3, Josamycine, Josamicina, Josamycinum, Antibiotic yl-704 A3, Josamycine [INN-French], Josamycinum [INN-Latin], Josamicina [INN-Spanish], Josacine, Yl-704 A3, 16846-24-5, Leucomycin V, 3-acetate 4B-(3-methylbutanoate), UNII-HV13HFS217, EN-141, Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate), EINECS 240-871-6, HV13HFS217, Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate), CHEBI:31739, Leucomycin V 3-acetate 4b-(3-methylbutanoate), JM, ST075007, Stereoisomer of 4-(acetyloxy)-6-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-(3-methyl-1-oxobutyl)-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-diene-7-acetaldehyde, Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4''-isovalerate, Leucomycin V 3-acetate 4(beta)-(3-methylbutanoate), EN 141, Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4'-isovalerate, Josamycin [USAN:INN:JAN], CCRIS 8511, NSC122223, Josamycin [USAN:INN:BAN:JAN], Josamycin (TN), AC1NQZL5, SCHEMBL132829, CHEMBL224436, Josamycin (JP17/USAN/INN), Josamycin, >=98.0% (UV), XJSFLOJWULLJQS-NGVXBBESSA-N, HY-B1920, 8158AH, MFCD00210320, ZINC96006021, Leucomycin A3 (Kitasamycin component), DB01321, [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate, LS-87883, LS-185083, TR-007321, CS-0013975, C12662, D01235, leucomycin V 3-acetate 4(B)-(3-methylbutanoate), SR-01000883731, SR-01000883731-1, Josamycin, European Pharmacopoeia (EP) Reference Standard, UNII-G986N7X02W component XJSFLOJWULLJQS-NGVXBBESSA-N, hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate, Josamycin for peak identification, European Pharmacopoeia (EP) Reference Standard, (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate, [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyl-tetrahydropyran-3-yl]oxy-4-hydroxy-2,4-dimethyl-tetrahydropyran-3-yl] 3-methylbutanoate, [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-, 56689-45-3, 6-{6-[(1S,13S,2R,3R,7R,14R,16R)-3-acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl -5-oxo-16-(2-oxoethyl)-6-oxacyclohexadeca-9,11-dienyloxy](3S,2R,4R,5R,6R)-4-(d imethylamino)-5-hydroxy-2-methyl(2H-3,4,5,, 6-{6-[3-Acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl-6-oxa-5-oxo-16-(2-oxoethyl)cyclohexadeca-9,11-dienyloxy]-4-(dimethylamino)-5-hydroxy-2-methylperhydro-2H-pyran-3-yloxy}-4-hydroxy-2,4-dimethylperhydro-2H-pyran-3-yl 3-methylbutanoate, 6-tetrahydropyran-3-yloxy)}(2S,3S,4R ,6R)-4-hydroxy-2,4-dimethyl-2H-3,4,5,6-tetrahydropyran-3-yl 3-methylbutanoate, Josamycin 10 microg/mL in Acetonitrile. Short expiry date due to chemical nature of component(s), iosalide, josamina, Wilprafen, josamycin propionate, C42H69NO15, EN141, C42-H69-N-O15, CID5282165, D015570, [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxa,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited